Thursday, February 23, 2017 2:15:34 PM
fingers Member Level Thursday, 02/23/17 02:06:25 PM
Re: None
Post # of 1830
Good day, xxxx
We will be actively keeping shareholders up to date on any definitive developments. We did have two mature convertible notes that have been converting and we will be updating investors when the notes have been completely repaid. I can’t speak as to when that may happen, but I can assure you that we will update immediately when the note(s) are repaid and there is no further conversion under those notes. We did have two small notes that we used as bridge financing. One for $77,000 and one for $55,000. We have zero intentions at this time of seeking any future financing that will be structured as a loan that is convertible to stock.
FNHI is hoping to raise $1,000,000 USD via a private placement offering to accredited investors. That, paired with our partnership with GunPowder Capital, will give us all of the capital we need to reach our revenue and growth targets in the North, Central, and South American markets. The use of proceeds are for inventory, new product development, and additional patents in our portfolio of four US / international patents.
Truxmart became a wholly owned subsidiary of FNHI (OTC listed trading entity) in/about November/2014 via a Reverse Merger. FNHI has always been a US listed company on the OTC markets. Truxmart is a Canadian corporation, wholly owed by FNHI. Our goal is to list on the Canadian Stock Exchange (a “dual listing”) to allow us to satisfy and grow our shareholder base in Canada, since it is rather difficult for a Canadian resident to deposit and trade OTC stock, in Canada. The CSE listing is simply a large step forward for the growth of FNHI and its wholly owned subsidiary, Truxmart. It will allow us market exposure in two contrives that we actively generate revenues from and we feel this step will bring great shareholder value.
To recap – we were always an OTC traded company – we are simply dually listing our common stock on the prestigious Canadian Stock Exchange for additional exposure and growth potentials in both the USA and Canada. We feel this is a extremely valuable step in our companies growth plan.
I sincerely love addressing any questions you have and I am available anytime for any questions, concerns, or comments. I will do my absolute best to answer any and all questions fully and quickly.
Recent GAXY News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:02:20 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/06/2023 04:15:21 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/05/2023 08:20:52 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 06/29/2023 08:04:58 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM